| Dr Marissa Galvez Vito Cruz, MD | |
|
16000 Johnston Memorial Dr, Fourth Floor, Abingdon, VA 24211-7664 | |
| (276) 258-4050 | |
| (276) 258-4056 |
| Full Name | Dr Marissa Galvez Vito Cruz |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 16000 Johnston Memorial Dr, Abingdon, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922071448 | NPI | - | NPPES |
| 1922071448 | Medicaid | VA | |
| 1527723 | Medicaid | TN | |
| P01245198 | Other | VA | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lonesome Pine Hospital | Big stone gap, VA | Hospital |
| Dickenson Community Hospital | Clintwood, VA | Hospital |
| Wellmont Holston Valley Medical Center | Kingsport, TN | Hospital |
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blue Ridge Medical Management Corporation | 9739099441 | 308 |
| Western Virginia Regional Emergency Physicians Llc | 4183991227 | 79 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Entity Name | Blue Ridge Medical Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326159567 PECOS PAC ID: 9739099441 Enrollment ID: O20040715001336 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Entity Name | United Emergency Services Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326007915 PECOS PAC ID: 5799697272 Enrollment ID: O20040731000104 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Entity Name | Norton Community Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861674160 PECOS PAC ID: 1557431665 Enrollment ID: O20080602000375 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Entity Name | Appalachian Emergency Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487963781 PECOS PAC ID: 6901099639 Enrollment ID: O20110120000558 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174808216 PECOS PAC ID: 8123291739 Enrollment ID: O20120627000467 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Entity Name | Western Virginia Regional Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386183028 PECOS PAC ID: 4183991227 Enrollment ID: O20170522001368 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Entity Name | App Of Tennessee Ed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003230236 PECOS PAC ID: 8123251766 Enrollment ID: O20180814002326 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marissa Galvez Vito Cruz, MD 200 Corporate Blvd, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Dr Marissa Galvez Vito Cruz, MD 16000 Johnston Memorial Dr, Fourth Floor, Abingdon, VA 24211-7664 Ph: (276) 258-4050 |
News Archive
The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.
British scientists say they have found a new way to regulate hypertension (high blood pressure).
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
› Verified 6 days ago
Jacquelyn Burt, Family Medicine Medicare: Medicare Enrolled Practice Location: 24530 Falcon Place Blvd, Suite 100, Abingdon, VA 24211 Phone: 276-619-0075 Fax: 276-619-0077 | |
Lura S Miller, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 613 Campus Dr, Suite 200, Abingdon, VA 24210 Phone: 276-628-1186 Fax: 276-628-8507 | |
Kaley Kuntz, Family Medicine Medicare: Medicare Enrolled Practice Location: 613 Campus Dr Ste 200, Abingdon, VA 24210 Phone: 276-628-1186 Fax: 276-628-8507 | |
Nermene George Wilson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Primary Care Center, 613 Campus Drive Suite #200, Abingdon, VA 24210 Phone: 714-326-6001 | |
Dr. Kellie Miranda Smith Blackwell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 117 Cook St, Abingdon, VA 24210 Phone: 276-619-5052 Fax: 276-619-5115 | |
William M Handy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 389 Falls Nwdr, Abingdon, VA 24210 Phone: 276-623-0740 Fax: 276-623-0660 | |
Lauren Ashley Mcgee, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-4435 |